Brief: China NT Pharma To Place Convertible Bonds In Principal Amount Of Up To HK$192.8 Mln
01/04/2019 14:08
April 1 (Reuters) - China NT Pharma Group Co Ltd 1011.HK :
* TO PLACE CONVERTIBLE BONDS IN AGGREGATE PRINCIPAL AMOUNT
OF UP
TO HK$192.8 MILLION AT INITIAL CONVERSION PRICE OF HK$0.60
Source text for Eikon: ID:nHKS6zVQnK
Further company coverage: 1011.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China NT Pharma
See all newsBrief: China NT Pharma Receives Cietac Beijing Arbitration Award On July 20
Brief: China NT Pharma Establishes Formal Whistleblowing Policy
Brief: China NT Pharma Group Says Zhang Bozhi Resigns As CEO
Brief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY